Trends in Antibiotic Use in the Outpatient Sector in France from 2015 to 2025

Antibiotic use in the outpatient sector in France declined between 2015 and 2025, with a 17% reduction in defined daily doses (DDD) and a 23.2% reduction in prescriptions. After a rebound in 2024, likely linked to bacterial outbreaks, the year 2025 marks a return to a downward trend, with consumption at 19.98 DDDs per 1,000 inhabitants per day and 740.93 prescriptions per 1,000 inhabitants per year. However, the stagnation in the consumption of critical antibiotics—which are drugs with restricted indications that have a significant impact on the selection of bacterial resistance (Group 2, French-Speaking Society of Infectious Diseases)—which account for 35% of prescriptions—as well as significant regional disparities in consumption trends, remain persistent challenges. A range of public health measures—such as rapid diagnostic tests (RDTs) deployed in pharmacies or other initiatives aimed at improving the appropriate use of antibiotics—have likely contributed to this trend, but further efforts are needed to achieve national and European targets.

Author(s): Ben Hmidene Ghaya, Piednoir Emmanuel, Marquet Aurélie, Opatowski Marion, Maugat Sylvie, Lefrançois Rémi

Publishing year: 2026

Pages: 540-548

Weekly Epidemiological Bulletin, 2026, n° 25-26, p. 540-548

In relation to

Our latest news

Appel à candidatures d'experts pour le remplacement d’un membre « sage-femme » du Comité national d'experts sur la mortalité maternelle (CNEMM)

news

Call for Nominations to Fill Vacancies on the National Reference Centers...

news

Public Health France Conference: November 9, 2026

news

Shamonda Virus: First Human Case Detected in France—What Do We Know?